| Status: Medicine does not meet criteria for AWMSG assessment | |
Excluded from appraisal by AWMSG as meets exclusion criteria 1. See AWMSG criteria for appraising a medicine (PDF, 430Kb) for information. |
|
Medicine details |
|
| Medicine name | formoterol fumarate (Atimos®) |
| Formulation | 12 micrograms/actuation inhalation solution |
| Reference number | 150 |
| Indication | Long-term symptomatic treatment of persistent, moderate-to-severe asthma in patients requiring regular bronchodilator therapy in combination with long-term anti-inflammatory therapy (inhaled and/or oral glucocorticoids) |
| Company | Chiesi Ltd |
| BNF chapter | Respiratory system |
| Assessment type | N/A |
| Status | Medicine does not meet criteria for AWMSG assessment |
| Date of issue | 24/10/2005 |